Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer
Conditions
- Urothelial/Bladder Cancer, Nos
Interventions
- DRUG: Atezolizumab
- BIOLOGICAL: PGV001
- DRUG: Poly ICLC
- DRUG: Normal saline
Sponsor
Matthew Galsky
Collaborators